Pharmaceuticals

Alkermes Inc.'s (ALKS) pipeline received a boost with its candidate ALKS 33 faring well in a mid-stage study (n=400) in alcohol dependent patients. The candidate is being developed for treating patients suffering from reward disorders and other central nervous system (CNS) problems.  The study...

Santa Clara, California based biopharmaceutical company XenoPort, Inc. (XNPT) announced an offering of 4 million shares of its common stock at a price of $7.15 per share. The company also granted the underwriters a 30-day option to purchase up to an aggregate of 600,000 shares. Shares of XenoPort,...

  ·         Howard Stern continues his stint at Sirius XM Radio (NASDAQ: SIRI) after signing another five-year contract ·         Johnson & Johnson (NYSE: JNJ) was downgraded by Wells Fargo (WFC) from “outperform” to “neutral”, with the target price in the range of $64 to $65 ·        ...

Orexigen Therapeutics, Inc. (NASDAQ: OREX) are dropping more than 3% this morning, after being up as much as 154% yesterday, on news that the FDA approved its controversial weight loss drug. Shares of Vivus (NASDAQ: VVUS) and Arena Pharmaceuticals (NASDAQ: ARNA) also spiked on the news yesterday,...

  ·         Howard Stern continues his stint at Sirius XM Radio (NASDAQ: SIRI) after signing another five-year contract ·         Johnson & Johnson (NYSE: JNJ) was downgraded by Wells Fargo (WFC) from “outperform” to “neutral”, with the target price in the range of $64 to $65 ·        ...

Jefferies published its report on Auxilium Pharma (NASDAQ: AUXL) today after AUXL held live webcasts to view two Xiaflex procedures. In its report, Jefferies writes, "For a one-hour introduction, we felt the live webcast provided an excellent clinical introduction to the data for Xiaflex and...

Johnson & Johnson (NYSE: JNJ) was downgraded by Wells Fargo from "outperform" to "market perform." JNJ's shares closed at $62.45 yesterday. Johnson & Johnson's PEG ratio is 2.20. Powell Industries Inc (NASDAQ: POWL) was downgraded by Roth Capital from "buy" to "neutral." POWL's stock closed...

XenoPort Inc (NASDAQ: XNPT) dipped 7.35% to $7.19 in the pre-market session. XNPT announced the pricing of its public offering of 4 million shares at $7.15 per share. American Capital Agency Corp (NASDAQ: AGNC) lost 5.12% to $28 in the pre-market session. AGNC announced secondary offering of 8,000,...

lululemon athletica inc (NASDAQ: LULU) rose 9.62% to $61.06 in the pre-market session. LULU reported upbeat Q2 results. Hi-Tech Pharmacal Co Inc (NASDAQ: HITK) added 4.64% to $25.50 in pre-market trading. HITK posted 10% y/y rise in its FQ2 net sales. Teva Pharmaceutical Industries (NASDAQ: TEVA)...

Hi-Tech Pharmacal Co., Inc. (Nasdaq: HITK) announced on Thursday morning that it easily beat consensus Wall Street estimates. Hi-Tech Pharmacal Co., Inc reported that its 2nd quarter net income rose to $10.0 million, or 76 cents per share, up from $7.4 million, or 60 cents per share, a year earlier...

Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) today reported results for the quarter ended October 31, 2010. For the three months ended October 31, 2010, the Company reported net sales of $44.9 million, an increase of 10% from $40.9 million for the same period last year. Net income for the three...

Analysts at Wells Fargo Securities downgrade Johnson & Johnson (NYSE: JNJ) from "outperform" to "market perform." JNJ's shares gained 0.22% to close at $62.45 yesterday. More Analyst Ratings here

Eye-care and surgical products maker Cooper Companies Inc. (COO) reported healthy fourth-quarter fiscal 2010 (ended October 31) results with adjusted earnings per share of $1.09 outdoing the Zacks Consensus Estimate of 86 cents and the year-ago earnings of 67 cents. For fiscal 2010, adjusted...

Orexigen Therapeutics Inc. (OREX) received a boost when an advisory panel of the US Food and Drug Administration (FDA) voted in favor of approving its obesity drug, Contrave. Contrave, a combination therapy, aims at addressing the physiological and behavioral causes of obesity. The FDA's...